Sequent Scientific Ltd.

115.30 -4.45 ▼-3.7%

28 March 2024, 04:01:00 PM
Volume: 98,296

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sequent.in
Market Cap 2,875.97 Cr.
Enterprise Value(EV) 3,236.18 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -5.15 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.46 Trailing Twelve Months Ending 2023-12
Book Value / Share 25.75 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.48 Calculated using Price: 115.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 24.94 Cr. 249,433,495 Shares
FaceValue 2
About Sequent Scientific Ltd.
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. Pursuant to the Scheme of Amalgamation as approved by the Honourable High Court Bombay vide its order dated June 16, 2009 Company made requisite application to the Registrar of Companies Mumbai for change of its name from PI Drugs & Pharmaceuticals Ltd. to Sequent Scientific Ltd. Accordingly Registrar of Companies approved the application and issued fresh Certificate of Incorporation consequent upon change in name dated October 27, 2009 and with effect from the date the name of Company changed to Sequent Scientific Ltd.

Sequent Scientific Ltd. Delivery

Delivered Qty
Traded Qty

Sequent Scientific Ltd. Performance

1 Day
-3.72%
1 Week
+2.17%
1 Month
-16.72%
3 Month
-1.75%
6 Month
+23.53%
1 Year
+68.67%
2 Year
-14.50%
5 Year
+59.70%
10 Year
+211.45%

Sequent Scientific Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -159.4 -3.67 -1.47 1.28 8.63 12.06 15 6.56 -18.95
Return on Capital Employed (%) -3.91 2.5 1.05 4.84 9.24 12.59 16.24 7.01 -9.71
Return on Assets (%) -8.62 -1.46 -0.81 0.63 4.14 5.73 7.19 3.06 -7.99

Sequent Scientific Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 91 946 977 648 707 687 728 692 699 632
Non Curr. Liab. 278 300 246 227 215 216 154 209 258 149
Curr. Liab. 406 290 545 431 440 515 513 537 559 602
Minority Int. 147 2 17 37 40 45 49 48 50 51
Equity & Liab. 922 1,538 1,904 1,343 1,402 1,463 1,443 1,487 1,566 1,434
Non Curr. Assets 612 1,047 1,176 805 796 739 676 678 743 661
Curr. Assets 310 476 594 538 606 724 767 808 812 773
Misc. Exp. not W/O
Total Assets 922 1,538 1,904 1,343 1,402 1,463 1,443 1,487 1,566 1,434

Sequent Scientific Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 443 606 684 848 1,039 1,179 1,362 1,413 1,421 1,375
Other Income 10 13 11 17 9 10 10 11 6 9
Total Income 453 620 695 864 1,048 1,189 1,372 1,424 1,427 1,384
Total Expenditure -425 -551 -641 -765 -914 -1,009 -1,152 -1,303 -1,409 -1,349
PBIDT 28 68 54 100 134 180 220 120 18 34
Interest -43 -38 -28 -33 -33 -36 -24 -16 -36 -47
Depreciation -32 -46 -40 -41 -42 -51 -51 -52 -56 -60
Taxation -3 -3 1 -13 -2 -12 -32 -8 16 23
Exceptional Items -17 -2 -9 -65 -74
PAT -67 -18 -14 10 57 82 104 45 -122 -123
Minority Interest 1 -2 3 -9 -8 -12 -9 -4 1 -5
Share Associate
Other Related Items
Consolidated Net Profit -11 -18 -14 422 49 70 95 41 -121 -129
Adjusted EPS -1 -1 -1 17 2 3 4 2 -5 -5

Sequent Scientific Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -45 -24 0 -7 45 116 115 115 31 17
Cash Fr. Inv. -80 -155 -316 -116 7 -68 -72 10 -96 -65
Cash Fr. Finan. 146 179 309 147 -57 -20 -43 -139 67 32
Net Change 21 1 -7 24 -5 28 0 -14 2 -16
Cash & Cash Eqvt 23 22 20 44 40 68 68 54 58 42

Sequent Scientific Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 53.02 53.02 52.79 52.79 52.79 52.79 52.79 52.79 52.79
Public 46.98 46.98 47.21 47.21 47.21 47.21 47.21 47.21 47.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Sequent Scientific Ltd. Announcements

Mon, 11 Mar 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results of Postal ballot pursuant to regulation 44 of the SEBI (Listing obligation and disclosure requirements) Regulations 2015 and Scrutinizers Report
Mon, 11 Mar 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results of Postal ballot pursuant to regulation 44 of the SEBI (Listing obligation and disclosure requirements) Regulations 2015 and Scrutinizers Report
Thu, 22 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Earnings Call Transcript as per Regulation 30 of SEBI (LODR) Regulations 2015

Sequent Scientific Ltd. Technical Scans

Thu, 28 Mar 2024
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
MFI Trending Up MFI Trending Up

Sequent Scientific Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,957.73 6,171.85 +2.0%
Zydus Lifesciences Ltd. 102,006.97 1,007.35 +0.8%
Divi's Laboratories Ltd. 91,654.35 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. 91,265.15 6,347.35 +1.9%
Mankind Pharma Ltd. 91,163.91 2,300.75 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.69 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.30 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 66.27 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.63 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 52.78 2,300.75 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.83 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.41 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.03 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.51 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.26 2,300.75 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%

Sequent Scientific Ltd. FAQ's

What is Sequent Scientific share price?

Can I buy Sequent Scientific shares now?

What is the Market Cap of Sequent Scientific?

What are the key metrics to analyse Sequent Scientific?

What is the 52 Week High and Low of Sequent Scientific?

What is the trend of Sequent Scientific share price?